Dr. Mark James Goodwin, MD

Dr. Goodwin practices at Edward Hospital in Naperville, Illinois, part of Endeavor Health.

Dr. Goodwin's NPI, 1639125867, was assigned on May 26, 2006. Dr. Goodwin graduated from Loyola University of Chicago, Stritch School of Medicine in 1984. Dr. Goodwin holds Illinois license 036.066770.

Dr. Goodwin's primary practice is Edward Hospital, at 801 South Washington, Naperville, IL 60540 in Du Page County. The practice phone is (630) 527-3000.

Dr. Goodwin's primary practice is Edward Hospital in Naperville, Illinois, part of Endeavor Health. Dr. Goodwin is also affiliated with Northwestern Medicine Central DuPage Hospital. The medical group on file is Edward Hospital. Dmand AI also links Dr. Goodwin to 3 more hospitals, 6 group practices and clinics and 6 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goodwin practices, 11 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Goodwin's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Goodwin is licensed in Illinois.

CMS data shows 4,068 Medicare services from Dr. Goodwin across 26 procedure codes in 2024, for 915 Medicare patients. Medicare paid $310,306 for them.

CMS counts 915 Medicare patients who saw Dr. Goodwin in 2024. The largest group is 75 to 84, with 403 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Goodwin's median patient age at 68, with 38% women.

In 2024, Dr. Goodwin wrote 6,701 Medicare Part D claims for 898 patients. 90% of them were for generic drugs. CMS names the drug for 6,425 of them, across 62 drugs with 11 or more claims each, at $649,823 in total drug cost. In 2023, CMS named 5,566 claims across 56 drugs.

Dr. Goodwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 40 procedures of coronary angioplasty and stenting by Dr. Goodwin, more than 76% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Goodwin in 2024. Dr. Goodwin's most frequent co-authors are Ofelia A. Alvarez, MD, Vasilis C. Babaliaros, MD and Cheryl D. Courtlandt, MD.

Dmand AI links Dr. Goodwin to 13 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Peripheral Arterial Disease, Peripheral Vascular Diseases and Myocardial Infarction. C. R. Bard sponsors the most, 3. Open Payments lists research payments to Dr. Goodwin that name 3 trials.

CMS Open Payments shows 798 general payments to Dr. Goodwin from 54 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 27% of the total. Edwards Lifesciences Corporation paid the most, $100,474. It also lists 20 research payments totaling $19,048 from 2016 to 2024, naming 3 clinical trials.

Dr. Goodwin graduated from Loyola University of Chicago, Stritch School of Medicine in 1984.